BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16189260)

  • 1. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes.
    Chan SS; Twigg SM; Firth SM; Baxter RC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6588-95. PubMed ID: 16189260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes.
    Assefa B; Mahmoud AM; Pfeiffer AFH; Birkenfeld AL; Spranger J; Arafat AM
    Oxid Med Cell Longev; 2017; 2017():3035184. PubMed ID: 29422987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo.
    Kim HS; Ali O; Shim M; Lee KW; Vuguin P; Muzumdar R; Barzilai N; Cohen P
    Pediatr Res; 2007 Feb; 61(2):159-64. PubMed ID: 17237715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
    Gericke MT; Schröder T; Kosacka J; Nowicki M; Klöting N; Spanel-Borowski K
    Mol Cell Endocrinol; 2012 Jan; 348(1):27-32. PubMed ID: 21801810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes.
    Heart E; Choi WS; Sung CK
    Am J Physiol Endocrinol Metab; 2000 Jan; 278(1):E103-12. PubMed ID: 10644543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes.
    Wada T; Hori S; Sugiyama M; Fujisawa E; Nakano T; Tsuneki H; Nagira K; Saito S; Sasaoka T
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E881-8. PubMed ID: 20071559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression.
    Jager J; Grémeaux T; Cormont M; Le Marchand-Brustel Y; Tanti JF
    Endocrinology; 2007 Jan; 148(1):241-51. PubMed ID: 17038556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes.
    Fukuoka H; Iida K; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi M; Okimura Y; Kaji H; Chihara K; Takahashi Y
    Growth Horm IGF Res; 2010 Jun; 20(3):212-9. PubMed ID: 20185348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of TFAM protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance and mitochondrial dysfunction.
    Shi CM; Xu GF; Yang L; Fu ZY; Chen L; Fu HL; Shen YH; Zhu L; Ji CB; Guo XR
    Cell Biochem Biophys; 2013 Jul; 66(3):489-97. PubMed ID: 23274913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3.
    Chan SS; Schedlich LJ; Twigg SM; Baxter RC
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E654-63. PubMed ID: 19141684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro.
    Mochizuki T; Sakai K; Iwashita M
    Growth Horm IGF Res; 2006 Jun; 16(3):202-10. PubMed ID: 16844395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
    Devi GR; Yang DH; Rosenfeld RG; Oh Y
    Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes.
    Xu M; Hu J; Zhao W; Gao X; Jiang C; Liu K; Liu B; Huang F
    Mol Nutr Food Res; 2014 May; 58(5):931-41. PubMed ID: 24343960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin is a direct inhibitor of glucose transport in adipocytes.
    Green A; Krause J; Rumberger JM
    Phytomedicine; 2014 Jan; 21(2):118-22. PubMed ID: 24060216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis.
    Boney CM; Moats-Staats BM; Stiles AD; D'Ercole AJ
    Endocrinology; 1994 Nov; 135(5):1863-8. PubMed ID: 7525256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea (-)-epigallocatechin gallate suppresses IGF-I and IGF-II stimulation of 3T3-L1 adipocyte glucose uptake via the glucose transporter 4, but not glucose transporter 1 pathway.
    Ku HC; Tsuei YW; Kao CC; Weng JT; Shih LJ; Chang HH; Liu CW; Tsai SW; Kuo YC; Kao YH
    Gen Comp Endocrinol; 2014 Apr; 199():46-55. PubMed ID: 24486085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes.
    Lundgren M; Burén J; Ruge T; Myrnäs T; Eriksson JW
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2989-97. PubMed ID: 15181089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.